| Application no. and date | 17163446.2 (espacenet) (Federated) (European Patent Register), 20100816 | | Patent/reg. no. and date | DK/EP 3311828, 20210407 | | Publication date | 20180425 | | Priority no. and date | US 234151 P, 20090814 | | EP pub. no. and date |
EP 3311828 20180425 | | Effective date | | | Applicant/owner | Phasebio Pharmaceuticals, Inc., One Great Valley Parkway
Suite 30
Malvern, Pennsylvania 19355, US | | Applicant ref. no. | 1591170 | | Inventor | TURNER, Andrew, c/o PHASEBIO PHARMACEUTICALS INC.
One Great Valley Parkway
Suite 30
Malvern, Pennsylvania 19355, US,
SADEGHI, Homayoun, c/o PHASEBIO PHARMACEUTICALS INC.
One Great Valley Parkway
Suite 30
Malvern, Pennsylvania 19355, US,
DAGHER, Suzanne, C/o Phasebio Pharmaceuticals Inc.
One Great Valley Parkway
Suite 30
Malvern, Pennsylvania 19355, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 38/00 (2006.01) , A61K 38/24 (2006.01) , A61P 37/00 (2006.01) , A61P 9/00 (2006.01) , A61P 9/12 (2006.01) | | Title | MODIFICEREDE VASOAKTIVE TARMPEPTIDER | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
